Comparing right vs. left chest surgery for junction cancer
Part of Injuries & trauma clinical trials.
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have adenocarcinoma (a type of cancer) at the junction where the esophagus meets the stomach (Siewert type II).
- Your cancer is in a stage where it can be completely removed by surgery (R0 resectable, T2-3, any lymph node status, no spread to other organs).
- You are generally healthy enough for surgery (ECOG performance status 0 or 1).
- You are between 18 and 80 years old.
- You have not had any previous chemotherapy, radiation, or other treatment for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different surgical approaches for removing Siewert type II cancer at the esophagus–stomach junction. It aims to find which operation works best for people who can have the tumor removed.
This study compares different ways to rebuild the digestive tract after removing the upper part of the stomach for cancer. It aims to find which method works best for eating and quality of life.
This trial compares two surgical techniques for treating a specific type of cancer at the junction of the stomach and esophagus. It aims to find which surgery offers better outcomes for patients.
This study tests a new robotic surgery system for a specific type of stomach-adjacent cancer. The goal is to see if the robotic approach is safe and effective in removing the tumor.
This trial compares two types of stomach-removing surgeries (total vs. partial gastrectomy) in people with a certain kind of advanced gastroesophageal junction cancer. The goal is to find out which surgery leads to better outcomes.
This study compares two ways to perform surgery for esophageal cancer. The goal is to see if doing the surgery with minimally invasive techniques (using small incisions and cameras) is as safe and effective as a hybrid method that uses both small and larger incisions. Your participation may help doctors improve surgical options for future patients.
Hear when a new Siewert Type II Adenocarcinoma of Esophagogastric Junction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.